SCHEMBL9493336

SCHEMBL9493336

COc1cccc(C2(O)CN3CCCC2C3)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 7/20 0.57
SLC6A2 P23975 6/20 0.56
SLC6A3 Q01959 3/20 0.56
OPRD1 P41143 5/20 0.47
SLC22A1 O15245 3/20 0.47
OPRM1 P35372 3/20 0.47
OPRK1 P41145 3/20 0.47
CHRM2 P08172 1/20 0.47
CHRM1 P11229 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
ALDH1A1 P00352 1/20 0.46
OPRL1 P41146 1/20 0.42
CHRNA1 P02708 1/20 0.42
CHRNG P07510 1/20 0.42
CHRNB1 P11230 1/20 0.42
CHRNB2 P17787 1/20 0.42
CHRNB4 P30926 1/20 0.42
CHRNA3 P32297 1/20 0.42
CHRNA4 P43681 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL9493456 0.95 SLC6A4 (0.53) SLC6A4SLC6A2SLC6A3OPRD1SLC22A1
SCHEMBL9492616 0.92 SLC6A4 (0.53) SLC6A4SLC6A2SLC6A3OPRD1SLC22A1
Oxalic Acid SCHEMBL9492481 0.89 ALDH1A1 (0.48) SLC6A4SLC6A2SLC6A3OPRD1SLC22A1
SCHEMBL9494213 0.87 SLC6A4 (0.54) SLC6A4SLC6A2SLC6A3OPRD1SLC22A1
SCHEMBL9492494 0.84 CHRM1 (0.56) SLC6A4SLC6A2SLC6A3OPRD1SLC22A1
Oxalic Acid SCHEMBL9495666 0.81 CHRM1 (0.50) SLC6A4SLC6A2SLC6A3OPRD1SLC22A1
SCHEMBL9493463 0.78 SLC6A4 (0.50) SLC6A4SLC6A2SLC6A3OPRD1OPRK1
SCHEMBL3228160 0.76 SLC6A4 (0.43) SLC6A4SLC6A2SLC6A3
SCHEMBL9492487 0.72 SLC6A4 (0.46) SLC6A4SLC6A2SLC6A3OPRD1OPRM1
SCHEMBL9264030 0.72 KMT2A (0.54) CHRM2CHRM1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0412797-A2 The therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes MERCK SHARP & DOHME LTD. (GB) 1991-02-13 EP claimed
US-5177084-A 1-Azabicycles, Treating Mental Disorders MERCK SHARP & DOHME LTD. (GB) 1993-01-05 US disclosed
EP-0412797-A2 The therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes MERCK SHARP & DOHME LTD. (GB) 1991-02-13 EP disclosed